Anti-CD3 × Anti-Epidermal Growth Factor Receptor (EGFR) Bispecific Antibody Redirects T-Cell Cytolytic Activity to EGFR-Positive Cancers <i>In vitro</i> and in an Animal Model

Ursula Reusch(Immunovaccine (Canada)), Lawrence G. Lum(University of Virginia), Magesh Sundaram(Roger Williams Medical Center), Sarah D. Olson, Paul Y. Liu(Brown University), Kurt Demel(Immunovaccine (Canada)), James B. Davis(University of Idaho), Ritesh Rathore(Boston University), Pamela A. Davol(Immunovaccine (Canada)), Julie Nissim(Immunovaccine (Canada))
Clinical Cancer Research
January 1, 2006
Cited by 106


Related Papers